Table: Chordia Therapeutics - 9-MTH parent results
Jul 16 (Reuters)-
Chordia Therapeutics Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
May 31, 2024 May 31, 2023 Aug 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 1.18 loss 2.27
Recurring loss 1.18 loss 2.28
Net loss 1.18 loss 2.28
EPS loss 20.86 yen loss 40.40 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Chordia Therapeutics Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T